FactSet (FDS) Q2 2026 earnings review
Top-Line Acceleration Prompts Guidance Raise Despite Planned Margin Squeeze
FactSet's strategy to trade near-term margins for structural growth is paying off. The company delivered its fifth consecutive quarter of accelerating organic Annual Subscription Value (ASV) growth, reaching 6.7% in Q2. Revenue grew 7.1% YoY to $611 million. However, the bottom line reflects the telegraphed investment cycle: adjusted operating margins contracted 230 basis points to 35.0%, and GAAP net income fell 8.1% due to an impairment charge and tech investments. Buoyed by early AI monetization and a strong pipeline, management raised full-year targets for ASV, revenue, and EPS, while continuing an aggressive share buyback program ($163M in the quarter).
🐂 Bull Case
Organic ASV growth has accelerated steadily from 4.1% in Q2 2025 to 6.7% today. Management is successfully capturing demand for enterprise data solutions and proving that their platform is gaining share rather than facing structural risk.
Free Cash Flow surged 23.6% to $185.7M. FactSet is aggressively deploying this cash, repurchasing $163M in stock during the quarter, supported by a newly authorized $1 billion buyback program.
🐻 Bear Case
The planned technology and AI investment cycle has heavily compressed margins. Adjusted operating margin fell from 37.3% to 35.0% YoY, limiting the flow-through of revenue beats to the bottom line.
GAAP Net Income declined 8.1% and GAAP EPS dropped 4.5%. This was exacerbated by an impairment charge on an equity investment, along with rising employee and software amortization expenses.
⚖️ Verdict: 🟢
Bullish. FactSet is executing its strategy flawlessly. The top-line acceleration proves client demand is robust, fully justifying the current margin investment cycle. Upgrading full-year guidance confirms this momentum is sustainable.
Key Themes
Organic ASV Growth Accelerating Firm-Wide
FactSet added $38.0 million in Organic ASV over the last three months, pushing the YoY organic growth rate to 6.7%. This was driven by institutional buy-side and wealth management clients. It marks an ongoing, stable acceleration from the 4-5% range seen throughout early FY25.
AI Integration Driving Early Monetization
Management directly cited early AI contributions—both in client engagement and internal operations—as a key driver. Specific rollouts like 'AI Doc Ingest' for the Cobalt Portfolio Monitoring platform highlight how FactSet is turning unstructured document extraction into a tangible, monetizable product for private capital clients. Additionally, FactSet integrated AI-driven financial crime risk management into its Workstation via ComplyAdvantage.
Margin Squeeze from Structural Tech Spend
The company's deliberate strategy to invest in AI, data expansion, and infrastructure is taking a heavy toll on margins. Q2 Adjusted Operating Margin dropped 230 bps YoY to 35.0%. Technology-related expenses and amortization of intangible assets are the primary culprits. While this was telegraphed in late FY25, investors must watch for when these investments will generate the promised operating leverage.
EMEA Growth Lags Other Geographies
While overall growth is accelerating, the EMEA region is noticeably lagging. EMEA organic ASV grew just 4.3% to $594.2 million, decelerating significantly compared to the Americas (+7.0%) and the standout APAC region (+10.0%). If European macro conditions weigh on client budgets, this segment could drag down the total company average.
Expanding Key Data Partnerships
FactSet continues to solidify its moat by becoming the infrastructure backbone for major players. They announced a multi-year strategic agreement with Barclays to support their long-term market data strategy, and integrated Kepler Cheuvreux Aftermarket Research, expanding European equity coverage across over 1,000 stocks.
Other KPIs
Accelerating. FCF jumped 23.6% YoY, easily outpacing revenue growth. This was driven by a 21.7% increase in operating cash flows. The company is successfully converting its top-line momentum into hard cash, enabling robust stock repurchases.
Reversing. Down 4.5% from $3.76 in the prior year. The drop was largely driven by a $10.2M impairment charge on an equity investment, higher employee costs, and increased tax rates (up to 17.4% from 15.9% due to limitations on executive compensation deductibility).
Stable. The company added 98 net new clients and 1,489 users over the past three months. Annual ASV retention remains exceptional at greater than 95%, with client retention at 91%, indicating that FactSet is holding its ground while successfully executing land-and-expand strategies.
Guidance
Accelerating. Upgraded from the previous range of $100 - $150 million. FactSet is currently running at the very top of this new range (6.7% in Q2). This implies management expects the current elevated growth trajectory to be maintained through the remainder of the fiscal year.
Accelerating. Raised from the previous $2,423 - $2,448 million range. The new midpoint ($2,460 million) represents roughly a 6% YoY increase from FY25's $2,321 million, firmly anchoring the company's growth story.
Stable. Unchanged from previous guidance. This solidifies the narrative that FY26 is a structural investment year. It represents a visible step down from FY25's 36.3% margin, as management prioritizes tech, AI, and data infrastructure spend.
Accelerating. Raised from the previous $16.90 - $17.60 range. The strong revenue flow-through and a lower expected share count (due to accelerated buybacks) are more than offsetting the planned margin contraction.
Key Questions
Margin Recovery Timeline
Adjusted operating margins are being held in the 34-35.5% range to fund necessary AI and tech infrastructure investments. At what point in FY27 or beyond should investors expect to see operating leverage return and margins expand back toward historical 37%+ levels?
EMEA Deceleration
Organic ASV growth in EMEA was just 4.3%, significantly trailing the Americas and APAC. Is this a result of broader European macro weakness, competitive displacement, or specific product mix headwinds?
AI Product Cannibalization vs. Expansion
As tools like 'AI Doc Ingest' for Cobalt become integrated into client workflows, are these resulting in add-on modular pricing, or are they table stakes required for renewals? Are we seeing true net-new ASV from these distinct SKUs?
Equity Investment Impairment
The quarter included a $10.2 million impairment charge on an equity investment within Other Assets. Can you provide color on the nature of this specific investment and whether further write-downs are anticipated?